Logo image of RDCM

RADCOM LTD (RDCM) Stock Fundamental Analysis

USA - NASDAQ:RDCM - IL0010826688 - Common Stock

14.57 USD
+0.03 (+0.21%)
Last: 9/22/2025, 9:01:25 PM
14.57 USD
0 (0%)
After Hours: 9/22/2025, 9:01:25 PM
Fundamental Rating

5

Taking everything into account, RDCM scores 5 out of 10 in our fundamental rating. RDCM was compared to 279 industry peers in the Software industry. While RDCM has a great health rating, its profitability is only average at the moment. RDCM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

RDCM had positive earnings in the past year.
The reported net income has been mixed in the past 5 years: RDCM reported negative net income in multiple years.
Of the past 5 years RDCM 4 years had a positive operating cash flow.
RDCM Yearly Net Income VS EBIT VS OCF VS FCFRDCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.90%, RDCM is in the better half of the industry, outperforming 76.70% of the companies in the same industry.
Looking at the Return On Equity, with a value of 9.02%, RDCM is in the better half of the industry, outperforming 74.55% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 4.07%, RDCM is in the better half of the industry, outperforming 72.04% of the companies in the same industry.
Industry RankSector Rank
ROA 6.9%
ROE 9.02%
ROIC 4.07%
ROA(3y)2.17%
ROA(5y)-0.7%
ROE(3y)2.89%
ROE(5y)-0.87%
ROIC(3y)N/A
ROIC(5y)N/A
RDCM Yearly ROA, ROE, ROICRDCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

RDCM's Profit Margin of 14.00% is fine compared to the rest of the industry. RDCM outperforms 77.78% of its industry peers.
Looking at the Operating Margin, with a value of 8.54%, RDCM is in the better half of the industry, outperforming 72.40% of the companies in the same industry.
The Gross Margin of RDCM (75.13%) is better than 67.74% of its industry peers.
RDCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.54%
PM (TTM) 14%
GM 75.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y1.07%
RDCM Yearly Profit, Operating, Gross MarginsRDCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so RDCM is destroying value.
Compared to 1 year ago, RDCM has more shares outstanding
RDCM has more shares outstanding than it did 5 years ago.
RDCM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RDCM Yearly Shares OutstandingRDCM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
RDCM Yearly Total Debt VS Total AssetsRDCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 5.28 indicates that RDCM is not in any danger for bankruptcy at the moment.
RDCM has a better Altman-Z score (5.28) than 68.46% of its industry peers.
There is no outstanding debt for RDCM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 5.28
ROIC/WACC0.43
WACC9.42%
RDCM Yearly LT Debt VS Equity VS FCFRDCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

RDCM has a Current Ratio of 4.92. This indicates that RDCM is financially healthy and has no problem in meeting its short term obligations.
RDCM has a better Current ratio (4.92) than 88.89% of its industry peers.
A Quick Ratio of 4.87 indicates that RDCM has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 4.87, RDCM belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.92
Quick Ratio 4.87
RDCM Yearly Current Assets VS Current LiabilitesRDCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 23.08% over the past year.
The Revenue has grown by 19.21% in the past year. This is quite good.
The Revenue has been growing by 13.07% on average over the past years. This is quite good.
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
Revenue 1Y (TTM)19.21%
Revenue growth 3Y14.84%
Revenue growth 5Y13.07%
Sales Q2Q%19.3%

3.2 Future

Based on estimates for the next years, RDCM will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.09% on average per year.
RDCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.42% yearly.
EPS Next Y16.57%
EPS Next 2Y9.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.4%
Revenue Next 2Y14.42%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
RDCM Yearly Revenue VS EstimatesRDCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
RDCM Yearly EPS VS EstimatesRDCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.18, RDCM is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of RDCM indicates a rather cheap valuation: RDCM is cheaper than 84.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, RDCM is valued a bit cheaper.
RDCM is valuated correctly with a Price/Forward Earnings ratio of 14.58.
Compared to the rest of the industry, the Price/Forward Earnings ratio of RDCM indicates a rather cheap valuation: RDCM is cheaper than 84.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, RDCM is valued a bit cheaper.
Industry RankSector Rank
PE 15.18
Fwd PE 14.58
RDCM Price Earnings VS Forward Price EarningsRDCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RDCM is valued a bit cheaper than 70.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 36.49
RDCM Per share dataRDCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

RDCM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.92
PEG (5Y)N/A
EPS Next 2Y9.09%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RDCM!.
Industry RankSector Rank
Dividend Yield N/A

RADCOM LTD

NASDAQ:RDCM (9/22/2025, 9:01:25 PM)

After market: 14.57 0 (0%)

14.57

+0.03 (+0.21%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-11 2025-11-11/bmo
Inst Owners53.91%
Inst Owner Change1.29%
Ins Owners14.85%
Ins Owner ChangeN/A
Market Cap233.56M
Analysts85
Price Target18.36 (26.01%)
Short Float %0.63%
Short Ratio1.32
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.74%
Min EPS beat(2)8.93%
Max EPS beat(2)22.55%
EPS beat(4)4
Avg EPS beat(4)15.62%
Min EPS beat(4)8.93%
Max EPS beat(4)22.55%
EPS beat(8)8
Avg EPS beat(8)27.8%
EPS beat(12)12
Avg EPS beat(12)86.29%
EPS beat(16)16
Avg EPS beat(16)91.86%
Revenue beat(2)2
Avg Revenue beat(2)0.89%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.55%
Revenue beat(4)4
Avg Revenue beat(4)2.24%
Min Revenue beat(4)0.22%
Max Revenue beat(4)3.72%
Revenue beat(8)8
Avg Revenue beat(8)2.31%
Revenue beat(12)10
Avg Revenue beat(12)1.65%
Revenue beat(16)13
Avg Revenue beat(16)1.53%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.44%
EPS NY rev (1m)0%
EPS NY rev (3m)2.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.34%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.01%
Valuation
Industry RankSector Rank
PE 15.18
Fwd PE 14.58
P/S 3.49
P/FCF N/A
P/OCF N/A
P/B 2.25
P/tB 2.3
EV/EBITDA 36.49
EPS(TTM)0.96
EY6.59%
EPS(NY)1
Fwd EY6.86%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.18
BVpS6.49
TBVpS6.34
PEG (NY)0.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.9%
ROE 9.02%
ROCE 5.15%
ROIC 4.07%
ROICexc 4.07%
ROICexgc 4.16%
OM 8.54%
PM (TTM) 14%
GM 75.13%
FCFM N/A
ROA(3y)2.17%
ROA(5y)-0.7%
ROE(3y)2.89%
ROE(5y)-0.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y1.07%
F-ScoreN/A
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.92
Quick Ratio 4.87
Altman-Z 5.28
F-ScoreN/A
WACC9.42%
ROIC/WACC0.43
Cap/Depr(3y)43.86%
Cap/Depr(5y)54.9%
Cap/Sales(3y)0.49%
Cap/Sales(5y)0.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)23.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25%
EPS Next Y16.57%
EPS Next 2Y9.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.21%
Revenue growth 3Y14.84%
Revenue growth 5Y13.07%
Sales Q2Q%19.3%
Revenue Next Year17.4%
Revenue Next 2Y14.42%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y665.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.94%
FCF growth 3Y89.23%
FCF growth 5Y11.48%
OCF growth 1Y133.55%
OCF growth 3Y76.52%
OCF growth 5Y9.97%